胰腺癌诊断及治疗的研究进展
Research Progress in Diagnosis and Treatment of Pancreatic Cancer
DOI: 10.12677/ACM.2023.13122816, PDF,   
作者: 熊文强：青海大学研究生院，青海 西宁；阳丹才让*：青海大学附属医院普通外科二，青海 西宁
关键词: 胰腺癌；诊断；治疗；Diagnosis and Treatment of Pancreatic Cancer
摘要: 胰腺癌由于胰腺特殊的解剖位置及本身生物学特性，加上缺乏典型的临床表现和有效的诊断方法，大多数胰腺癌患者确诊时已是晚期，手术切除率低，治疗效果差，80%以上胰腺癌患者发现时即为晚期，失去了有效的手术切除机会，预后极差。本文我们通过回顾胰腺癌的诊疗现状，重点综述其当前诊疗方法和治疗手段，并对胰腺癌当前诊疗面临的挑战和未来研究趋势进行更进一步的探讨。
Abstract: Due to the special anatomical location and biological characteristics of the pancreas, coupled with the lack of typical clinical manifestations and effective diagnostic methods, most pancreatic cancer patients are diagnosed at an advanced stage, with low surgical resection rate and poor treatment effect, and more than 80% of pancreatic cancer patients are found to be at an advanced stage, losing the opportunity for effective surgical resection, and the prognosis is extremely poor. In this article, we review the current status of diagnosis and treatment of pancreatic cancer, focus on its current diagnosis and treatment methods, and further discuss the challenges and future research trends of pancreatic cancer.
文章引用：熊文强, 阳丹才让. 胰腺癌诊断及治疗的研究进展[J]. 临床医学进展, 2023, 13(12): 19995-20000. https://doi.org/10.12677/ACM.2023.13122816

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Zheng, R., Zhang, S., Zeng, H., et al. (2022) Cancer Incidence and Mortal-ity in China, 2016. Journal of the National Cancer Center, 2, 1-9. [Google Scholar] [CrossRef] [PubMed]
[3] Ferlay, J., Partensky, C. and Bray, F. (2016) More Deaths from Pancreatic Cancer than Breast Cancer in the EU by 2017. Acta Oncologica, 55, 1158-1160. [Google Scholar] [CrossRef] 
[4] Li, N., Wu, P., Shen, Y., et al. (2021) Predictions of Mor-tality Related to Four Major Cancers in China, 2020 to 2030. Cancer Communications, 41, 404-413. [Google Scholar] [CrossRef] [PubMed]
[5] Carioli, G., Malvezzi, M., Bertuccio, P., et al. (2021) European Cancer Mortality Predictions for the Year 2021 with Focus on Pancreatic and Female Lung Cancer. Annals of Oncology, 32, 478-487. [Google Scholar] [CrossRef] [PubMed]
[6] 中华医学会肿瘤学分会早诊早治学组. 中华医学会肿瘤学分会胰腺癌早诊早治专家共识[J]. 临床肝胆病杂志, 2020, 36(12): 2675-2680.
[7] Zhao, Z. and Liu, W. (2020) Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technology in Cancer Research & Treatment, 19. [Google Scholar] [CrossRef] [PubMed]
[8] 郭臣, 刘文, 张园园. 多排螺旋CT与MR对胰腺癌的诊断意义探析[J]. 影像研究与医学应用, 2021, 5(24): 194-196.
[9] 谢晓燕. 超声内镜和超声造影在胰腺局灶性病变诊断中的应用[J]. 中华医学超声杂志(电子版), 2011, 8(7): 1402-1407.
[10] Gleeson, F.C., Kipp, B.R., Caudill, J.L., et al. (2010) False Positive Endoscopic Ultrasound Fine Needle Aspiration Cytology: Incidence and Risk Factors. Gut, 59, 586-593. [Google Scholar] [CrossRef] [PubMed]
[11] Krishnan, K., Bhutani, M.S., Aslanian, H.R., et al. (2021) Enhanced EUS Imaging (with Videos). Gastrointestinal Endoscopy, 93, 323-333. [Google Scholar] [CrossRef] [PubMed]
[12] Sugimoto, M., Takagi, T., Suzuki, R., et al. (2017) Con-trast-Enhanced Harmonic Endoscopic Ultrasonography in Gallbladder Cancer and Pancreatic Cancer. Fukushima Journal of Medical Science, 63, 39-45. [Google Scholar] [CrossRef] [PubMed]
[13] Tamagno, G., Scherer, V., Caimo, A., et al. (2018) Endoscopic Ultra-sound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study. Digestion, 98, 112-118. [Google Scholar] [CrossRef] [PubMed]
[14] Kitano, M., Yoshida, T., Itonaga, M., et al. (2019) Impact of Endoscopic Ultrasonography on Diagnosis of Pancreatic Cancer. Jour-nal of Gastroenterology, 54, 19-32. [Google Scholar] [CrossRef] [PubMed]
[15] Ge, L., Pan, B., Song, F., et al. (2017) Comparing the Diagnostic Accuracy of Five Common Tumour Biomarkers and CA19-9 for Pancreatic Cancer: A Protocol for a Network Meta-Analysis of Diagnostic Test Accuracy. BMJ Open, 7, e018175. [Google Scholar] [CrossRef] [PubMed]
[16] Gemmel, C., Eickhoff, A., Helmstädter, L., et al. (2009) Pan-creatic Cancer Screening: State of the Art. Expert Review of Gastroenterology & Hepatology, 3, 89-96. [Google Scholar] [CrossRef] [PubMed]
[17] Kamisawa, T., Wood, L.D., Itoi, T., et al. (2016) Pancreatic Cancer. The Lancet, 388, 73-85. [Google Scholar] [CrossRef] 
[18] Lee, B. and Gibbs, P. (2019) Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer. Journal of Personalized Medicine, 9, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[19] Daamen, L.A., Groot, V.P., Heerkens, H.D., et al. (2018) Systematic Re-view on the Role of Serum Tumor Markers in the Detection of Recurrent Pancreatic Cancer. HPB, 20, 297-304. [Google Scholar] [CrossRef] [PubMed]
[20] He, J. (2014) Management of Borderline and Locally Advanced Pancreatic Cancer: Where Do We Stand? World Journal of Gastroenterology, 20, 2255-2266. [Google Scholar] [CrossRef] [PubMed]
[21] Dai, H.M., Hong, X.F., Pang, H.Y., Wu, W.M. and Zhao, Y.P. (2019) The Effect of Para-Aortic Lymph Node Metastasis on the Resectability of Pancreatic Cancer. Chinese Journal of Surgery, 57, 68-71.
[22] Shin, S.H., Kim, S.C., Song, K.B., et al. (2015) A Comparative Study of Laparoscopic vs. Open Distal Pancreatectomy for Left-Sided Ductal Adenocarcinoma: A Propensity Score-Matched Analysis. Journal of the American College of Surgeons, 220, 177-185. [Google Scholar] [CrossRef] [PubMed]
[23] Strobel, O., Neoptolemos, J., Jager, D. and Buchler, M.W. (2019) Optimizing the Outcomes of Pancreatic Cancer Surgery. Na-ture Reviews Clinical Oncology, 16, 11-26. [Google Scholar] [CrossRef] [PubMed]
[24] Seufferlein, T., Ham-mel, P., Delpero, J.R., et al. (2019) Optimizing the Management of Locally Advanced Pancreatic Cancer with a Focus on Induction Chemotherapy: Expert Opinion Based on a Review of Current Evidence. Cancer Treatment Reviews, 77, 1-10. [Google Scholar] [CrossRef] [PubMed]
[25] Springfeld, C., et al. (2019) Chemotherapy for Pancreatic Cancer. La Presse Médicale, 48, e159-e174. [Google Scholar] [CrossRef] [PubMed]
[26] Raza, M.H., Raza, M.H., Arshad, A., et al. (2019) Microbiota in Cancer Development and Treatment. Journal of Cancer Research and Clinical Oncology, 145, 49-63. [Google Scholar] [CrossRef] [PubMed]
[27] Riquelme, E., Maitra, A. and McAllister, F. (2018) Immunother-apy for Pancreatic Cancer: More than Just a Gut Feeling. Cancer Discovery, 18, 386-388. [Google Scholar] [CrossRef] 

为你推荐